UK Regulatory Group Responsibilities

The Regulatory group collaborates with the wider business to translate the constantly evolving requirements of the UK regulatory environment into Roche policies, procedures, solutions, and strategies that ensure compliance and maximize the value for patients.

• Clinical Trial Applications


• National Licensing Applications


• Early Access to Medicines Applications


• National components of medicines authorization via the European Centralized procedure

The team serves as Roche's primary contact with the MHRA, requiring effective cross‑functional collaboration at both local and global levels, as well as the capability to negotiate and influence externally. Regulatory Partners need to be adaptable and entrepreneurial to identify opportunities, while maintaining a focused approach on ensuring compliance and playing a key role in retaining Roche UK's License to Operate.